Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 7
2005 8
2006 6
2007 7
2008 9
2009 6
2010 12
2011 11
2012 7
2013 2
2014 7
2015 5
2016 6
2017 8
2018 5
2019 4
2020 6
2021 9
2022 3
2023 11
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Results by year

Filters applied: . Clear all
Page 1
Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
Gaba P, O'Donoghue ML, Park JG, Wiviott SD, Atar D, Kuder JF, Im K, Murphy SA, De Ferrari GM, Gaciong ZA, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Flores-Arredondo JH, López JAG, Elliott-Davey M, Wang B, Monsalvo ML, Abbasi S, Giugliano RP, Sabatine MS. Gaba P, et al. Among authors: toth k. Circulation. 2023 Apr 18;147(16):1192-1203. doi: 10.1161/CIRCULATIONAHA.122.063399. Epub 2023 Feb 13. Circulation. 2023. PMID: 36779348 Clinical Trial.
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.
Giugliano RP, Pedersen TR, Park JG, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Ott BR, Kanevsky E, Pineda AL, Somaratne R, Wasserman SM, Keech AC, Sever PS, Sabatine MS; FOURIER Investigators. Giugliano RP, et al. Among authors: toth k. Lancet. 2017 Oct 28;390(10106):1962-1971. doi: 10.1016/S0140-6736(17)32290-0. Epub 2017 Aug 28. Lancet. 2017. PMID: 28859947 Free article. Clinical Trial.
PARP inhibition and postinfarction myocardial remodeling.
Halmosi R, Deres L, Gal R, Eros K, Sumegi B, Toth K. Halmosi R, et al. Among authors: toth k. Int J Cardiol. 2016 Aug;217 Suppl:S52-9. doi: 10.1016/j.ijcard.2016.06.223. Epub 2016 Jun 28. Int J Cardiol. 2016. PMID: 27392900 Review.
Physical Properties of Blood and their Relationship to Clinical Conditions.
Alexy T, Detterich J, Connes P, Toth K, Nader E, Kenyeres P, Arriola-Montenegro J, Ulker P, Simmonds MJ. Alexy T, et al. Among authors: toth k. Front Physiol. 2022 Jul 6;13:906768. doi: 10.3389/fphys.2022.906768. eCollection 2022. Front Physiol. 2022. PMID: 35874542 Free PMC article. Review.
The Effects of SGLT2 Inhibitors on Lipid Metabolism.
Szekeres Z, Toth K, Szabados E. Szekeres Z, et al. Among authors: toth k. Metabolites. 2021 Feb 1;11(2):87. doi: 10.3390/metabo11020087. Metabolites. 2021. PMID: 33535652 Free PMC article. Review.
[Catheter ablation of ventricular tachycardias].
Mihálcz A, Szili-Török T, Tóth K. Mihálcz A, et al. Among authors: toth k. Orv Hetil. 2015 Jun 21;156(25):995-1002. doi: 10.1556/650.2015.30167. Orv Hetil. 2015. PMID: 26170087 Review. Hungarian.
Plasma viscosity: a forgotten variable.
Késmárky G, Kenyeres P, Rábai M, Tóth K. Késmárky G, et al. Among authors: toth k. Clin Hemorheol Microcirc. 2008;39(1-4):243-6. Clin Hemorheol Microcirc. 2008. PMID: 18503132 Review.
142 results